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Iduronic aidSynthesis of an array of differentially sulfated GlcN–IdoA disaccharides, accessible on good scale, directly
from L-iduronate components is described. These are speciﬁcally directed to provide the sulfation vari-
ability at the key most common biologically relevant sulfation-variable L-IdoA O-2 and D-GlcN O-6 and
amino sites of this heparin disaccharide. This sulfation-varied matrix has allowed the ﬁrst evaluation
of using Raman/ROA spectroscopy to characterize changes in spectra as a function of both site and level
of sulfation with pure, deﬁned heparin-related disaccharide species. This provides analysis of both sim-
ilarities and differences to digest native heparin and this shows evidence of different types of changes in
conformations and conformational freedom as a function of some speciﬁc sulfation changes at the disac-
charide level. It is anticipated that this data set will open the way for applications to further site-speciﬁc
sulfated saccharides and demonstrates the capability offered by Raman–ROA towards ﬁngerprinting sul-
fation in heparin fragments.
 2014 The Authors. Published by Elsevier Ltd. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/3.0/).1. Introduction saccharides) is also evidently inﬂuential on the conformationalHeparin and heparan sulfate (H/HS) are highly sulfated glycos-
aminoglycans (GAGs) involved in a variety of important biological
recognition processes.1–3 The main repeating disaccharide unit of
H/HS consists of an N-substituted D-glucosamine (GlcNX) unit
a-1,4 linked to L-iduronic acid (L-IdoA) or D-glucuronic acid
(D-GlcA). The rare L-IdoA sugar has some unique conformational
properties, in being able to adopt readily interconverting chair
(1C4 and 4C1) and skew-boat (2S0) conformers.4–6 This conforma-
tional plasticity has attracted considerable interest in seeking to
understand how this additional ﬂexibility of the idopyranose ring
relates to the central role of H/HS in binding to, and regulating
the biology of, a wide diversity of proteins. The conformational
preferences differ as a function of protein binding in binary or
ternary complexes7–11 although evidence suggests limited effects
on the overall 3D shape of longer oligosaccharides.12 The role of
sulfation state and the local environment (i.e., adjacent sugars inequilibria, and thus has been of interest from theoretical13–17 and
spectroscopic perspectives.18 Alongside backbone linkage and
monomer unit differences, variations of sulfation are also key
effectors in the biological roles of such oligosaccharides.19 There
is growing evidence that changes in sulfation sites can also have
a signiﬁcant impact on binding selectivity and/or biology, even in
shorter synthetic HS sequences or other GAGs.19–23
Although high resolution techniques such as crystallography
and NMR spectroscopy have been used to investigate carbohydrate
conformation, they are often difﬁcult to apply to complex saccha-
rides, and developing new methods to identify and characterize
structural features and conformational dynamics in glycosylami-
noglycans, such as the H/HS structures, are hence of great impor-
tance. Raman spectroscopy, which measures molecular
vibrations, and Raman optical activity (ROA), which measures the
small difference in Raman scattering from chiral molecules using
circularly polarized light, are two complementary techniques that
can provide such information. The combination of Raman and
ROA can provide highly detailed information about the structure
and conformational dynamics of biological molecules.24–26 Early
ROA studies on mono- and disaccharides have demonstrated the
sensitivity of ROA spectra to the identity of the sugar and the nat-
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study the details of higher order structure in the non-sulfated gly-
cosaminoglycan hyaluronan,30 glycan conformation in a high-man-
nose glycoprotein,31 and of the glycan of RNAseB32 and the effect of
hydration on methy-L-glucose dynamics.33 Although Raman has
been employed to begin to investigate the effects of sulfation on
carbohydrate structure,34,35 and ROA spectra have previously been
reported for H/HS,36 much work remains to be undertaken to
exploit the potential of ROA spectroscopy as a probe of structural
effects of sulfation upon carbohydrates.
The highly heterogeneous nature of native H/HS, both in terms
of backbone and sulfation patterns, means that access to structur-
ally well-deﬁned, simpliﬁed systems are essential in order to
develop the structural accuracy of such analytical methods, that
is, linking the speciﬁc and differentiated structural features of the
repeating unit to the data obtained from Raman/ROA. Of particular
interest in this context is characterizing the relationship of Raman/
ROA spectra to variations in GAG sulfation patterns and the inﬂu-
ence this has on conformational dynamics. To this end we report
here the synthesis of a [GlcN–IdoA] library of methyl glycoside-
capped disaccharides containing deﬁned sulfation patterns across
the IdoA O2, GlcN O6 and 2-amino sites (native sulfation sites),
as a programmed matrix of sulfation variations for analysis using
Raman/ROA spectroscopy. Whilst the disaccharide is the minimal
unit to evaluate applications of Raman/ROA on sulfation variations,
the biological relevance of such disaccharides has also been evi-
denced by work involving protein-binding experiments.23
Whilst NMR data conﬁrm that the constituent monosaccharides
in all sulfated disaccharides adopt consistent ring conformations,
Raman/ROA identiﬁes spectral features indicative of different
effects on global conformation, which can be related to the varia-
tion in sites of sulfation. Comparison here with digest heparin indi-
cates that the disaccharide unit could prove a suitable model for
longer, sulfated heparin-related GAGs.
2. Heparin-like disaccharides
A diversity of sulfated disaccharides of the [IdoA–GlcN] type
obtained from enzymatic depolymerisation methods has been pre-
viously characterized by NMR,37 and a number of synthetic routes
to these types of HS disaccharide have been described.38 However,
the reverse sequence disaccharide unit [GlcN–IdoA] is also of inter-
est23,39,40 and it is the repeat unit in a number of longer synthetic
heparanoid mimetics recently reported.19,41,42 This led us to target
the synthesis of a sulfation-varied matrix of this repeat unit
through our readily accessible L-idopyranoside 1,19 chosen as the
preferred acceptor for disaccharide incorporation, as it has the a-
conﬁguration found in native heparin linkages.
Differentially-protected thioglycoside and trichloroacetimidate
D-GlcN derivatives,43 having 2-azido non-participating groups
were thus chosen as complementary donors for the synthesis of
heparin-like disaccharides 4, 6 and 8 (Scheme 1). This set of disac-
charide targets was selected to enable divergence to a matrix of the
biologically-related, site-speciﬁc sulfation patterns incorporating
L-IdoA-O2S, D-GlcN-O6S and D-GlcNS, which are the key sites of
sulfation variation in native H/HS oligosaccharides (with obliga-
tory L-IdoA O2 sulfation). Moreover, variations in sulfation at these
sites (particularly N-2 and O-6 of D-GlcN) are strongly implicated
in many biological effects. An elegant approach recently reported
by Hung et al.23 also provides disaccharides of this type, exploiting
an L-iduronate-lactone based access (from a late stage L-iditol oxi-
dation). Here, we exploit pre-installation of the iduronate carbox-
ylate at the outset, which provides a complementary access to a
matrix of IdoA–GlcN disaccharides with different combinations of
sulfation at the common native sulfation sites.All glycosylations of 1 proceeded in good yields and high ano-
meric selectivities for formation of the desired a-linked disaccha-
rides and were utilized to access gram amounts of these key
intermediates, for example 4 was prepared on 1.8 g scale from 2
(Scheme 1). Disaccharide 4was formedwith no detectable amounts
of the b anomerwith utilization of either trichloroacetimidate (3) or
thiophenyl (2) as the anomeric leaving group. The D-GlcN-O6 ben-
zyl-protected donor 5 yielded 6 as a 6:1 a/b mixture (from 1H
NMR) of diastereoisomers which were readily separable by chro-
matography to afford the pure a anomer, again on gram-scale.
Anomeric selectivity and yield were also high for coupling 4,6-
benzylidene protected donor 7 with acceptor 1 to afford the ben-
zylidene-protected disaccharide 8. The utilization of a benzyli-
dene-protected D-GlcN unit was selected not only to access 4,6-
unsulfated compounds of type 18 (vide infra), but also to demon-
strate the utility of our thioglycoside donor/iduronate acceptor
system. This complements earlier systems developed using trichlo-
roacetimidate derived D-GlcN donors,44 providing an alternative
means to prepare disaccharide-level benzylidene systems, suitable
for late stage 4,6-positional manipulations.
Disaccharides 4, 6 and 8 were next taken through deprotection
and sulfation sequences to afford the ﬁnal sulfation-varied library.
Firstly, treatment of all three disaccharides with LiOH in THF/
MeOH/H2O provided the disaccharide carboxylic acids 9–11
(Scheme 2). This step was necessary to expose the L-IdoA-O2 posi-
tion for sulfation on all species, whilst retaining options for selec-
tivity at the GlcN-O6 position.
Thus, 2,6-di-O-sulfation of 9 and individual 2-O-sulfation of 10,
afforded intermediates 12 and 13 respectively, in good yields. Sub-
sequent hydrogenolysis then removed all benzylic ether linkages
with concomitant azide reduction to afford heparin-like disaccha-
rides 14 and 15, differing only in their D-GlcN-O6 sulfation. Finally,
N-sulfation was completed using SO3pyridine complex in water to
afford the D-GlcNS6S and D-GlcNS disaccharides 16 and 17 respec-
tively (Scheme 3). This afforded four alternative variants of the
ﬁnal sulfation pattern for this disaccharide scaffold (14–17).
Alongside this we also wanted to diverge to the corresponding
disaccharide lacking any sulfation. This would complete a matrix
from completely non-sulfated to fully trisulfated variants, encom-
passing the main patterns seen in native heparin-like species. To
access this unsulfated disaccharide, benzylidene-protected disac-
charide 11 was exhaustively hydrogenolized to give the fully
deprotected and unsulfated D-GlcN–L-IdoA species 18 (Scheme 4).
The synthetic approach detailed here thus allows a convenient
access to a matrix of the key, biologically-relevant and differen-
tially sulfated H/HS disaccharides. These are a useful tool-kit to
investigate structural analysis of these minimal disaccharide
repeat units of the native ligands.
The 1H NMR spectra of 14–18 were consistent with the antici-
pated effects of adding sulfation at O-2 of L-IdoA and NH2 of GlcN
on their respective anomeric protons (in all cases approximately
0.2–0.3 ppm shift downﬁeld). These data are overlaid in Figure 1.
1H NMR data also showed the presence of a rare J2,4 ‘W’ coupling
in compound 15, indicating L-iduronate components of the disac-
charide adopting a 1C4 conformation (see Section 5).
Whilst these 1H NMR data can conﬁrm shift effects, they do not
readily provide indicative data about conformational change more
broadly. We thus selected disaccharides 15–18, which contain an
increasing sulfation content (zero to three sulfates overall), for fur-
ther analysis by Raman/ROA spectroscopy.
3. Raman/ROA analysis of HS disaccharides
In Figure 2 we present the Raman (top, IR + IL) and ROA (bottom,
IR  IL) spectra of (a) 18; (b) 15; (c) 17 and (d) 16, together with (e)
Scheme 1. Reagents and conditions: (a) NIS, AgOTf, DCM, 92% for 4 via 2, 77% for 6 (6:1 a/b), 80% for 8 (12:1, a/b) (b) TMSOTf, DCM, 95% for 4 via 3.
Scheme 2. Reagents and conditions: (a) LiOH, THF/MeOH/H2O, 58% for 9, 75% for 10, 90% for 11.
46 G.J. Miller et al. / Carbohydrate Research 400 (2014) 44–53a commercial sample of heparin. Thus, we can directly compare the
Raman and ROA spectra of the nonsulfated, sulfated, disulfated and
trisulfated native forms of the GlcN–IdoA disaccharide. Differences
are observable between these spectra, showing that Raman and
ROA spectra are sensitive to the effects of sulfation on disaccharide
conformation, which are discussed below.
The region between 900–1100 cm1 in the Raman spectra pre-
sents the most obvious differences due to sulfation. A number of
small-to-medium sized Raman features are found for the non-sul-
fated disaccharide (18), with a number of more intense and sharp
bands then appearing for the different sulfated sugars. This is gen-
erally in good agreement with other reported Raman spectra ofsulfated glycosaminoglycans.45,46 In particular, a reasonably con-
sistent set of Raman bands assigned to OASAO3 vibrations can
be seen at 1075 cm1 for the mono-, di- and tri-sulfated disac-
charides (as a weak shoulder in the latter), suggesting that this
band originates from the 2-O sulfation site. A small, yet reliable,
band 896 cm1 also appears to show a singular sensitivity to 2-
O sulfation. The mono-sulfated compound 15 also generates a dou-
blet of peaks at 1037 cm1 and 1048 cm1, which appear to
merge into a stronger singlet at 1044 cm1 upon further sulfa-
tion. This observation is in agreement with the reported associa-
tion of this band with S@O symmetric stretching vibrations in N-
sulfates,47 as only the di- and tri-sulfated species (17 and 16) con-
Figure 1. Key anomeric region 1H NMR data for 1
Scheme 3. Reagents and conditions: (a) PySO3 complex, pyridine, 79% for 12, 72% for 13 (b) H2, Pd(OH)2/C, MeOH/H2O, 99% for 14, 99% for 15 (c) PySO3 complex, H2O, 79%
for 16, 92% for 17.
Scheme 4. Reagents and conditions: (a) H2, Pd(OH)2/C, H2O, MeOH, 95%.
G.J. Miller et al. / Carbohydrate Research 400 (2014) 44–53 47tain N-sulfation. A similar sharp increase occurs for the band
987 cm1, which is weak when no sulfate group is present, of
moderate intensity upon 2-O-sulfation and much more intense
upon addition of the other sulfate groups. This band appears to cor-
respond to those of CAOAS vibrations previously reported,46 but is
of far greater intensity here for the di- and tri-sulfated disaccha-
rides. In addition, there is a band nearby at 1001 cm1 for 15 that
either completely or mostly disappears in the spectra of the other
three samples. The most obvious difference for the spectrum of the
tri-sulfated species 16 compared to the others is the sharp doublet
appearing at 1631 and 1655 cm1. Furthermore, a band appears at
1066 cm1 in the tri-sulfated disaccharide, partly overlapping4–18 (Spectra recorded at 400 MHz in D2O).
Figure 2. Raman (IR + IL) and ROA (IR  IL) spectra for compounds 15–18, together with a set of spectra of commercially available heparin.
48 G.J. Miller et al. / Carbohydrate Research 400 (2014) 44–53with the 1075 cm1 band, and additionally, smaller bands at
828 cm1 and 1009 cm1. These three bands can hence be
assigned as suggestive markers for 6-O-sulfation.
The corresponding ROA spectra display a complex set of
changes in response to sulfation patterns. Overall these ROA spec-
tra display proﬁles similar to those reported by Rudd et al.36 for aheparin sample, particularly the strong +//+ triplet observed from
1100–1150 and and the /+ couplet couplet from 1300–
1400 cm1. Similar features were also reported by Zhu et al.48 for
N,N0-diacetylchitobiose. Increasing sulfation then gives rise to a
series of band changes. The +ve ROA bands at 1141, 1249 and
1378 cm1 all become more intense upon sulfation at the O2 site
G.J. Miller et al. / Carbohydrate Research 400 (2014) 44–53 49(15) but are then reduced upon N-sulfation (17). Within the com-
plex band structure 800–1000 cm1 the 2-O-sulfated and non-sul-
fated disaccharides display similar proﬁles, though the non-
sulfated disaccharide tends to display broader ROA bands and
two additional features at 899 and 955 cm1. One ROA marker
band for 2-O-sulfation does appear as a negative band at
823 cm1. Further sulfation at N2 and O6 (16) leads to substantial
decreases in the intensity of many of these ROA bands, while the
pattern remains intact. Interestingly, we note that many of these
ROA bands for the tri-sulfated form are very similar to those of
the di-sulfated form. These spectral variations all suggest that sul-
fation at the O2 site leads to relatively few changes in the confor-
mation of the D-GlcN–a-1,4-L-IdoA-OMe disaccharide, but does
reduce to some degree the conformational mobility of the carbohy-
drate. Spectral changes suggest subsequent sulfation at the GlcN–
NH2 site does lead to signiﬁcant conformational changes and also
an increase in conformational freedom of the disaccharide.
The most signiﬁcant spectral variations occur in the region of
500–600 cm1. At slightly lower wavenumber, from 400–
500 cm1, in the ROA spectra for each of these four disaccharides
we observe small couplets that are +ve at lower wavenumber
and ve at higher wavenumber, that are typical of the a-1–4 link-
age type.49 Although these couplets do show some variability in
position and shape they all clearly verify the existence of the a-
1–4 linkage, as other linkage types show sign inversion of these
spectral features. This consistent proﬁle identifying the linkage
between the two sugar rings is in stark contrast to the intense
ve/+ve ROA couplet at 497/549 cm1 measured for the mono-
sulfated disaccharide and the strong ve band 566 cm1 for the
di- and tri-sulfated forms. Such features have not been reported
previously in the ROA spectra of carbohydrates and no assignment
is yet available for these bands. However, it does appear that this
band monitors signiﬁcant differences in a structural moiety.
Although the identity of this structural feature is not yet known,
it is possible that this band originates from CAOAS stretching coor-
dinates mixing with CANAS stretching vibrations.
In order to further study the sensitivity of ROA towards sulfa-
tion patterns in related native GAGs, we measured the Raman
and ROA spectra of a commercial sample of heparin, also presented
in Figure 2. The Raman spectrum of heparin is again (and as previ-
ously reported in literature) dominated by intense bands arising
from the sulfate moieties. The Raman bands at 896 cm1 and
1049 cm1 (slightly shifted from 1044 cm1) indicate 2-O- and
N-sulfation, respectively, while the bands at 828 cm1,
1009 cm1 and 1066 cm1 are clear indicators of 6-O-sulfation.
Interestingly, no Raman bands are observed at 987 cm1 or
1075 cm1 in the heparin spectrum. As the marker band for 2-O-
sulfation at 896 cm1 is present in the heparin spectrum, the lack
of the 1075 cm1 band clearly indicates that this band is more
prone to conformational shifting and must be overlapping with
the 1066 cm1 band in heparin. Therefore, the 896 cm1 is a
more reliable marker for 2-O-sulfation.
The ROA spectrum of heparin reveals some intriguing similari-
ties, and differences, when compared to the spectra of the disac-
charides. While the ROA spectrum of heparin is quite similar to
those of the di- and tri-sulfated disaccharides in the lowwavenum-
ber region (up to 900 cm1), implying similar conformational dis-
tributions and sulfation patterns, the highly conserved region in
the ROA spectra of the disaccharides, between 1000 and
1200 cm1, changes fundamentally in the spectrum of heparin.
Johannessen et al.31 reported a corresponding similarity between
the low frequency ROA signatures for the glycan component of
invertase and those of component mannose saccharides, and con-
cluded that the conformations around the glycosidic linkages in
the intact glycoprotein were likely to be similar to those adopted
by the free sugars. Above 1000 cm1 the complicated pattern ofROA bands is reduced to one couplet, ve at 1114 cm1 and
+ve at 1138 cm1. Above 1200 cm1, the ROA spectrum of hepa-
rin is again similar to those of the N-sulfated disaccharides, and the
tri-sulfated disaccharide in particular.4. Conclusions
An efﬁcient, short route to an array of differentially sulfated
GlcN–IdoA disaccharides has been identiﬁed, demonstrating that
these targets can be routinely accessed on good scale, directly from
L-iduronate components. These are speciﬁcally directed to provide
the sulfation variability at the key biologically-relevant L-idoA O-2
and D-GlcN O-6 and amino sites. This has allowed the ﬁrst evalua-
tion of using Raman/ROA spectroscopy to characterize changes in
spectra as a function of both site and level of sulfation with pure,
deﬁned species. This has provided new data to correlate to sulfa-
tion level and also enabled categorization of both similarities and
differences to native digest heparin. Data suggest evidence of
changes in conformations and conformational freedom as a func-
tion of speciﬁc sulfation-site changes at the disaccharide level. It
is anticipated that this data set will open the way for applications
to further site-speciﬁc sulfated saccharides.5. Experimental section
5.1. Raman and Raman optical activity measurements
All Raman and ROA experiments were performed using a Chi-
ralRaman spectrometer (BioTools Inc, Jupiter FL, USA) operated
via Critical Link LLC software. The instrument was set up in the
backscattering geometry using a Millenium Pro Nd/VO4 laser
(SpectraPhysics, UK) with an excitation wavelength of 532 nm,
laser power at sample 400 mw, spectral resolution 7 cm1
and total acquisition times of 24 h. The parent Raman spectra
(IR + IL) and the ROA difference spectra (IR  IL) were recorded
simultaneously. For each sample 100 lL of solution was ﬁltered
through a 0.22 lm spin ﬁlter (Merck Millipore, Germany) prior to
being pipetted into a quartz cell (Starna, UK).
5.1.1. Methyl 6-O-acetyl-2-azido-3-O-benzyl-2-deoxy-4-O-p-
methoxybenzyl-a-D-glucopyranosyl-(1?4)-(methyl 2-O-
benzoyl-3-O-benzyl-a-L-idopyranoside)uronate 4
5.1.1.1. From thioglycoside donor 2. Glucosamine derived
donor 2 (1.65 g, 2.97 mmol) and acceptor 1 (950 mg, 2.28 mmol)
were mixed together, evaporated from dry toluene (3  20 mL)
and left under high vacuum for 1 h. The suspension was diluted
under a nitrogen atmosphere with dry DCM (45 mL) and 4 Å
molecular sieves (800 mg) added. The mixture was cooled to 0 C
and NIS (2.5 g, 11.4 mmol) added. Then the mixture was stirred
for a further 15 min at the same temperature whereupon a cata-
lytic amount of AgOTf was added. The mixture was kept under a
nitrogen atmosphere at 0 C for a further 30 min. The suspension
was then quenched by addition of a 1:1 mixture of saturated aque-
ous solution of Na2S2O3 and NaHCO3 (10 mL total) and ﬁltered
through Celite. The phases were separated and the organic layer
washed with brine. The crude was then puriﬁed by column chro-
matography (EA/hexane 1:4?2:3), to yield 4 (1.8 g, 2.10 mmol,
92%) as a foam.
5.1.1.2. From trichloroacetimidate donor 3. Both reaction
components, trichloroacetimidate 3 (430 mg, 1.04 mmol) and alco-
hol 1 (855 mg, 1.42 mmol) were combined, co-evaporated from
dry toluene (3  10 mL) and dried under high vacuum for 1 h. To
this mixture was added dry DCM (20 mL) and reaction was cooled
to 30 C. TMSOTf (2 lL, 0.01 mmol) was added and reaction mon-
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(30 min). Then the reaction was quenched by addition of Et3N
(0.2 mL) and solvents were evaporated in vacuo. The product 4
(850 mg, 0.99 mmol, 95%) was isolated after column chromatogra-
phy (EtOAc/hexane 2:9). Rf = 0.5 (EtOAc/hexane 1:3); [a]D20 = 13.0
(c 10.0, CH2Cl2); 1H NMR (400 MHz; CDCl3) d 8.13 (dd, J = 8.8,
1.2 Hz, 2H, Ph), 7.48–7.13 (m, 15H, Ph), 6.90 (d, J = 8.8 Hz, 2H,
Ph), 5.13 (br s, 1H, H-1), 5.10 (br s, 1H, H-2), 4.95 (d, J = 12.0 Hz,
1H, CH2Ph), 4.85 (d, J = 2.0 Hz, 1H, H-5), 4.78 (d, J = 12.0 Hz, 1H,
CH2Ph), 4.67 (d, J = 3.2 Hz, 1H, H-10), 4.65 (d, J = 12.0 Hz, 1H, CH2
Ph), 4.47 (d, J = 10.8 Hz, 1H, CH2Ph), 4.38 (dd, J = 12.0, 2.4 Hz, 1H,
H-60A), 4.28 (dd, J = 12.0, 3.2 Hz, 1H, H-60B), 4.15–4.09 (m, 2H, CH2
Ph, H-3), 4.03–3.97 (m, 3H, H-40, H-4, H-50), 3.95 (d, J = 10.8 Hz, 1H,
CH2Ph), 3.85 (s, 3H, OCH3), 3.82 (s, 3H, OCH3), 3.52 (s, 3H,
C(O)OCH3), 3.46 (t, J = 10.0 Hz, 1H, H-30), 3.18 (dd, J = 10.0, 3.2 Hz,
1H, H-20), 2.04 (s, 3H, C(O)CH3); 13C NMR (100 MHz; CDCl3) d
170.6, 169.6, 165.5, 159.4, 137.7, 137.4, 133.3, 130.0, 129.7,
129.6, 128.8, 128.5, 128.4, 128.2, 128.1, 127.8, 113.8, 100.4, 99.7,
80.2, 76.1, 74.67, 74.51, 72.7, 72.4, 70.2, 67.8, 66.9, 63.8, 62.4,
56.3, 55.3, 52.5, 20.9; HRMS (FT-MS NSI+) m/z calcd for
C45H53N4O14 [M+NH4]+ 873.3555, found 873.3553.
5.1.2. Methyl 2-azido-3,6-di-O-benzyl-2-deoxy-4-O-p-
methoxybenzyl-a-D-glucopyranosyl-(1?4)-(methyl 2-O-
benzoyl-3-O-benzyl-a-L-idopyranoside) uronate 6
Acceptor monosaccharide 1 (0.83 g, 2.04 mmol) and thioglyco-
side donor 5 (1.46 g, 2.45 mmol) were dissolved in dry DCM
(15 mL) under N2. Freshly activated 4 Å powdered molecular sieves
(0.59 g) were added and the solution cooled to 15 C. After
10 min, NIS (0.92 g, 4.09 mmol) was added and after another
10 min AgOTf (10 mg, 0.041 mmol) added. The suspension chan-
ged colour from pale yellow to deep red, was stirred for 45 min
and more AgOTf added (10 mg, 0.041 mmol). The reaction was
quenched after 2½ h into a separating funnel containing a mixture
of DCM (100 mL), saturated aqueous NaHCO3 (80 mL) and Na2S2O3
(20 mL, 10% aqueous). After shaking until the iodine colour was
removed, the suspension was ﬁltered through a short pad of Cel-
ite washing with water and DCM. The layers were separated
and the aqueous extracted with DCM (20 mL). The organic layers
were combined, dried (MgSO4) and solvent removed in vacuo.
The material was puriﬁed by silica gel ﬂash column chromatogra-
phy (EtOAc/hexane 1:2) to give 6 (1.40 g, 1.55 mmol, 77%) as a
white foam. Rf = 0.32 (EtOAc/hexane 1:2); [a]D20 = 48.0 (c 1.0, CH2
Cl2); 1H NMR (400 MHz; CDCl3) d 8.01 (dd, J = 8.4, 1.2 Hz, 2H, Ph),
7.35–7.14 (m, 16H, Ph), 7.04 (dd, J = 7.7, 1.6 Hz, 2H, Ph), 6.98 (d,
J = 8.7 Hz, 2H, Ph), 6.77 (d, J = 8.7 Hz, 2H, Ph), 5.04 (s, 1H, H-1),
4.98 (s, 1H, H-2), 4.84 (d, J = 11.9 Hz, 1H, CH2Ph), 4.75 (d,
J = 2.0 Hz, 1H, H-5), 4.68 (d, J = 11.9 Hz, 1H, CH2Ph), 4.62 (d,
J = 3.5 Hz, 1H, H-10), 4.51 (t, J = 10.6 Hz, 2H, CH2Ph), 4.39 (d,
J = 12.0 Hz, 1H, CH2Ph), 4.33 (d, J = 10.5 Hz, 1H, CH2Ph), 4.09 (d,
J = 10.8 Hz, 1H, CH2Ph), 4.04 (br s, 1H, H-3), 3.94 (t, J = 2.4 Hz, 1H,
H-4), 3.84–3.79 (m, 2H, CH2Ph, H-60A), 3.74 (s, 3H, OCH3), 3.73–
3.71 (m, 1H, H-60B), 3.66 (s, 3H, OCH3), 3.61–3.55 (m, 2H, H-40,
H-50), 3.44–3.40 (m, 4H, H-30, C(O)OCH3), 3.12 (dd, J = 10.2,
3.5 Hz, 1H, H-20); 13C NMR (100 MHz; CDCl3) d.169.6, 165.5,
159.2, 137.9, 137.8, 137.4, 133.2, 130.6, 130.0, 129.6, 129.4,
128.8, 128.5, 128.4, 128.3, 128.3, 128.2, 128.0, 127.8, 127.7,
127.66, 113.6, 100.4, 100.0, 80.0, 77.4, 76.0, 74.6, 74.4, 73.6, 73.0,
72.4, 71.7, 67.8, 67.1, 63.7, 56.2, 55.3, 52.3; HRMS (ESI+) m/z calcd
for C50H53N3O13Na [M+Na]+ 926.3471, found 926.3471.
5.1.3. Methyl 2-azido-3-O-benzyl-4,6-O-benzylidene-2-deoxy-a-
D-glucopyranosyl-(1?4)-(methyl 2-O-benzoyl-3-O-benzyl-a-L-
idopyranoside) uronate 8
Acceptor monosaccharide 1 (234 mg, 0.56 mmol) and thiogly-
coside donor 7 (355 mg, 0.75 mmol) were dissolved in dry DCM(4 mL) under N2. Freshly activated 4 Å powdered molecular sieves
(0.22 g) were added and the solution cooled to 0 C in an ice-bath.
After 10 min NIS (259 mg, 1.15 mmol) was added and after another
10 min AgOTf (7 mg, 0.03 mmol) was added. The suspension chan-
ged colour from pale yellow to deep red, was stirred for 45 min and
more AgOTf added (8 mg, 0.03 mmol). The reaction was quenched
after 90 min into a separating funnel containing a mixture of DCM
(30 mL), saturated aqueous NaHCO3 (30 mL) and Na2S2O3 (5 mL,
10% aqueous). After shaking until the iodine colour was removed,
the suspension was ﬁltered through a short pad of Celite washing
with water and DCM. The layers were separated and the aqueous
extracted with DCM (10 mL). The organic layers were combined,
dried (MgSO4) and solvent removed in vacuo. The crude was puri-
ﬁed by silica gel ﬂash column chromatography (EtOAc/hexane 1:3)
to give 8 (353 mg, 80%, 0.45 mmol, a/b 12:1) as a white foam. Rf
0.21 (EtOAc/Hexane 1:3); [a]D20 = +66.5 (c 0.7, CH2Cl2) Data for
major a anomer: 1H NMR (400 MHz; CDCl3) d 8.18–8.15 (m, 2H,
Bz), 7.53–7.13 (m, 18H, Ph), 5.53 (s, 1H, PhCHO), 5.16–5.15 (m,
1H, H-2), 5.14–5.13 (m, 1H, H-1), 4.96 (d, J = 12 Hz, 1H, CH2Ph),
4.88 (d, J = 2.0 Hz, 1H, H-5), 4.79 (d, J = 12 Hz, 1H, CH2Ph), 4.65
(d, J = 3.6 Hz, 1H, H-10), 4.44–4.41 (m, 1H, CH2Ph), 4.38 (dd,
J = 10.0, 4.8 Hz, 1H, H-40), 4.16–4.14 (m, 1H, H-3), 4.06–4.05 (m,
1H, H-4), 4.02 (dt, J = 9.6, 4.8 Hz, 1H, H-50), 3.96–3.93 (m, 1H, CH2
Ph), 3.81 (s, 3H, C(O)OCH3), 3.68–3.54 (m, 3H, H-30, H-60A, H-60B),
3.53 (s, 3H, OCH3), 3.21 (dd, J = 9.6, 3.6 Hz, 1H, H-20); 13C NMR
(100 MHz; CDCl3) d 169.6, 165.6, 137.9, 137.6, 137.5, 133.3,
130.0, 129.7, 129.1, 128.8, 128.5, 128.4, 128.1, 128.0, 127.8,
126.2, 101.5, 100.5, 99.9, 82.4, 76.7, 75.9, 74.8, 72.8, 72.5, 68.6,
67.8, 67.0, 63.5, 63.2, 56.3, 52.4; HRMS (ESI+) m/z: calcd for C42H43
NaN3O12 [M+Na]+: 804.2739, found: 804.2720.
5.1.4. 2-Azido-3-O-benzyl-2-deoxy-4-O-p-methoxybenzyl-a-D-
glucopyranosyl-(1?4)-(methyl 3-O-benzyl-a-L-
idopyranoside)uronic acid 9
Disaccharide 4 (400 mg, 0.47 mmol) was dissolved in THF
(3.0 mL) and MeOH (1 mL). The solution was cooled to 0 C and
LiOH (105 mg, 1.88 mmol) in H2O (1 mL) was added dropwise.
The solution was stirred for 3 h at this temperature and quenched
with 1 M HCl (50 lL). Solvents were removed in vacuo and the res-
idue partitioned between EtOAc (50 mL) and water (10 mL). The
layers were separated, the organics dried (MgSO4) and solvent
removed in vacuo to give the crude material as a clear oil. This
was puriﬁed by silica gel ﬂash chromatography, eluting with
DCM/MeOH, 95:5 to give 9 (190 mg, 0.27 mmol, 58%) as a white
foam. Rf 0.41 (DCM/MeOH 9:1); [a]D20 = 40.3 (c 4.0, MeOH); 1H
NMR (400 MHz; MeOD) d 7.43–7.30 (m, 10H, Ph), 7.22 (d,
J = 8.7 Hz, 2H, Ph), 6.86 (d, J = 8.8 Hz, 2H, Ph), 5.13 (d, J = 3.8 Hz,
1H, H-10), 4.89 (d, J = 11.0 Hz, 1H, CH2Ph), 4.87 (d, J = 2.8 Hz, 1H,
H-1), 4.83–4.79 (m, 2H, CH2Ph), 4.73–4.68 (m, 3H, H-5, 2 CH2Ph),
4.63 (d, J = 10.5 Hz, 1H, CH2Ph), 4.18 (t, J = 3.3 Hz, 1H, H-4), 3.92 (t,
J = 4.1 Hz, 1H, H-3), 3.89–3.87 (m, 1H, H-30), 3.79 (s, 3H, PMBOCH3),
3.77–3.73 (m, 3H, H-50, H-60A, H-60B), 3.68–3.67 (m, 1H, H-2), 3.63
(t, J = 9.2 Hz, 2H, H-40), 3.57 (dd, J = 3.8, 10.3 Hz, 2H, H-20), 3.45 (s,
3H, OCH3); 13C NMR (100 MHz; CD3OD) d 172.9, 160.9, 139.5,
139.4, 131.7, 130.6, 129.5, 129.4, 129.0, 128.9, 128.7, 114.7,
104.0, 97.3, 81.9, 78.8, 76.4, 75.7, 75.5, 74.0, 73.8, 73.7, 69.5,
69.1, 65.2, 61.4, 56.5, 55.7; HRMS (FTMS NSI) m/z calcd for
C35H40N3O12 [MH] 694.2617, found 694.2607.
5.1.5. 2-Azido-3,6-di-O-benzyl-2-deoxy-4-O-p-methoxybenzyl-
a-D-glucopyranosyl-(1?4)-(methyl 3-O-benzyl-a-L-
idopyranoside)uronic acid 10
Disaccharide 6 (695 mg, 0.78 mmol) was dissolved in THF
(5.0 mL) and MeOH (2 mL). The solution was cooled to 0 C and
KOH (92 mg, 1.63 mmol) in H2O (2 mL) was added dropwise. The
solution was stirred for 3 h at this temperature. The reaction was
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(MgSO4), ﬁltered and solvent removed in vacuo to give the crude
material as a clear oil. This was puriﬁed by silica gel ﬂash chroma-
tography (EtOAc/Hexane 1:2 + 1% HCOOH) to give 10 (452 mg,
0.58 mmol, 75%) as a white foam. Further puriﬁcation was
achieved by crystallization (dissolved 0.35 g in 2 mL EtOAc and
added 6 mL hexane) to yield ﬁne white needles. Rf = 0.25 (EtOAc/
hexane 1:1 + 1% HCOOH); mp 118–119 C; [a]D20 = 18.8 (c 0.41,
CH2Cl2); 1H NMR (400 MHz; CDCl3) d 7.38–7.28 (m, 15H, Ph),
7.06 (d, J = 8.8 Hz, 2H, Ph), 6.80 (d, J = 8.8 Hz, 2H, Ph), 4.96–4.95
(m, 1H, H-1), 4.92 (d, J = 4.0 Hz, 1H, H-10), 4.88–4.67 (m, 5H, H-5,
2 CH2Ph), 4.64 (d, 1H, J = 12 Hz, CH2Ph), 4.60 (d, 1H, J = 12 Hz,
CH2Ph), 4.74–4.44 (m, 2H, d, 1H, J = 12 Hz, CH2Ph), 4.24–4.23 (m,
1H, H-3), 3.86–3.59 (m, 8H, H-2, H-4, H-20, H-30, H-40, H-50, H-
60A, H-60B), 3.78 (s, 3H, PMBOCH3), 3.45 (s, 3H, OCH3); 13C NMR
(100 MHz; CDCl3) d 170.4, 159.3, 137.6, 137.4, 137.2, 129.9,
129.5, 128.6, 128.5, 128.1, 128.1, 128.0, 128.0, 127.8, 113.8,
103.2, 95.4, 81.1, 77.4, 75.7, 74.5, 73.6, 72.2, 71.9, 71.7, 71.3,
68.3, 66.3, 66.0, 63.7, 56.4, 55.3; HRMS (ESI) m/z calcd for
C42H46N3O12 [MH] 784.3086, found 784.3099. Elemental analy-
sis calcd for C42H47N3O12: C 64.19, H 6.03, N 5.35; found C 64.23, H
6.27, N 5.35.
5.1.6. 2-Azido-3-O-benzyl-4,6-O-benzylidene-2-deoxy-a-D-
glucopyranosyl-(1?4)-(methyl 3-O-benzyl-b-L-
idopyranoside)uronic acid 11
Disaccharide 8 (310 mg, 0.40 mmol) was dissolved in THF
(5.0 mL) and MeOH (2 mL). The solution was cooled to 0 C and
KOH (57 mg, 1.02 mmol) in H2O (2 mL) was added dropwise. The
solution was stirred for 3 h at this temperature. The reaction was
extracted with EtOAc (2  25 mL) and HCl (25 mL, 0.1 M) and then
dried (MgSO4), ﬁltered and solvent removed in vacuo to give the
crude material as a clear oil. This was puriﬁed by silica gel ﬂash
chromatography (EtOAc/Hexane 1:2 + 1% HCOOH) to give 11
(235 mg, 0.38 mmol, 90%) as a white foam. Rf = 0.09 (EtOAc/hexane
1:1 + 1% HCOOH); [a]D20 = 71.5 (c 0.20, CH2Cl2); 1H NMR
(400 MHz; CDCl3) d 7.50–7.19 (m, 15H, Ph), 5.52 (s, 1H, PhCHO2),
4.95 (s, 1H, H-1), 4.93 (d, 1H, J = 10.8 Hz, CH2Ph), 4.85 (d,
J = 1.6 Hz, 1H, H-5), 4.78 (d, J = 4.4 Hz, 1H, H-10), 4.75 (d, 1H,
J = 10.8 Hz, CH2Ph), 4.74 (d, 1H, J = 12 Hz, CH2Ph), 4.59 (d, 1H,
J = 12 Hz, CH2Ph), 4.75–4.57 (m, 2H, CH2Ph), 4.30 (dd, J = 10.0,
4.8 Hz, 1H, H-40), 4.19–4.18 (m, 1H, H-4), 3.97 (t, J = 10.0 Hz, 1H,
H-30), 3.88–3.87 (m, 1H, H-2), 3.82–3.81 (m, 1H, H-3), 3.76 (dt,
J = 10.0, 4.8 Hz, 1H, H-50), 3.65 (d, J = 11.6 Hz, 1H, H-60A), 3.62 (d,
J = 10.8 Hz, 1H, H-60B), 3.58 (dd, J = 9.6, 4 Hz, H-20), 3.38 (s, 3H,
OCH3); 13C NMR (100 MHz; CDCl3) d 171.2, 137.8, 137.3, 137.1,
129.3, 129.2, 128.7, 128.6, 128.5, 128.4, 128.3, 128.3, 128.1,
128.0, 126.2, 125.5, 103.2, 101.6, 95.7, 82.0, 78.0, 75.4, 72.2, 71.9,
71.4, 68.4, 66.2, 66.1, 63.5, 63.3, 56.4; HRMS (ESI) m/z calcd for
C34H36N3O11 [MH] 662.2355, found 662.2357.
5.1.7. 2-Azido-3-O-benzyl-2-deoxy-4-O-p-methoxybenzyl-6-O-
sulfonato-a-D-glucopyranosyl-(1?4)-(methyl 3-O-benzyl-2-O-
sulfonato-a-L-idopyranoside)uronic acid di sodium salt 12
Disaccharide 9 (190 mg, 0.27 mmol) was dissolved in dry pyri-
dine (2.0 mL) under N2 at rt. SO3Py (258 mg, 1.62 mmol, 6.0 equiv)
was added and the suspension stirred at rt overnight. The reaction
was quenched by addition of NaHCO3 (350 mg) in H2O (1 mL) and
the solvents removed in vacuo. The crude white paste was then
puriﬁed by silica gel ﬂash chromatography, eluting with DCM/
MeOH, 9:1, 4:1 and the converted to the sodium form using with
Amberlite IRC 86 Na+ resin to give 12 (196 mg, 0.21 mmol, 79%)
as a white glass. Rf = 0.25 (5:1, DCM/MeOH + 1% NH4OH);
[a]D20 = 13.8 (c 0.6, MeOH); 1H NMR (400 MHR, MeOD) d 7.32–
7.14 (m, 12H, Ph), 6.70 (d, J = 8.7 Hz, 2H, PMB), 5.00 (d, J = 3.9 Hz,
1H, H-10), 4.90 (s, 1H, H-1), 4.85–4.81 (m, 2H, CH2Ph), 4.67 (d,1H, J = 10 Hz, CH2Ph), 4.65 (d, 1H, J = 12 Hz, CH2Ph), 4.56 (d, 1H,
J = 12 Hz, CH2Ph), 4.54 (d, 1H, J = 10 Hz, CH2Ph), 4.45 (d,
J = 1.6 Hz, 1H, H-5), 4.32–4.27 (m, 2H, H-2, H-60A), 4.15 (dd,
J = 10.9, 1.8 Hz, 1H, H-60B), 4.10 (s, 1H, H-3), 4.04 (s, 1H, H-4),
3.86 (dm, 1H, J = 12 Hz, H50), 3.79 (t, J = 9.6 Hz, 1H, H-30), 3.66 (s,
3H, PMBOMe), 3.55 (t, J = 9.6 Hz, 1H, H-40), 3.42 (dd, J = 10.2,
3.8 Hz, 1H, H-20), 3.31 (s, 3H, OMe); 13C NMR (100 MHz; MeOD) d
175.8, 160.8, 140.0, 139.2, 131.9, 131.2, 129.4, 129.3, 129.0,
128.8, 128.7, 128.6, 114.6, 101.6, 95.4, 82.2, 78.8, 76.3, 75.7, 73.0,
71.6, 71.4, 71.4, 71.3, 67.1, 65.6, 56.0, 55.7; HRMS (FT MS NSI)
m/z calcd for C35H39N3 NaO18S2 [MNa] 876.1573, found
876.1536.
5.1.8. 2-Azido-3,6-di-O-benzyl-2-deoxy-4-O-p-methoxybenzyl-
a-D-glucopyranosyl-(1?4)-(methyl 2-O-sulfonato-3-O-benzyl-
a-L-idopyranoside)uronic acid mono sodium salt 13
Disaccharide 10 (193 mg, 0.25 mmol) was dissolved in dry pyr-
idine (4.0 mL) under N2 at rt. Pyridine sulfur trioxide complex
(119 mg, 0.78 mmol) was added and the suspension stirred at rt
for 3 h. The reaction was quenched by addition of MeOH (0.3 mL)
and the solvents removed in vacuo. The crude white paste was
then puriﬁed by silica gel ﬂash chromatography (DCM/MeOH,
15:1, 10:1 to 5:1). The product was then converted to the disodium
salt by stirring with Amberlite IRC 86 Na+ resin (0.5 g) in MeOH
(6 mL) for 2 h, ﬁltered and evaporated to yield 13 (161 mg,
0.18 mmol, 72%) as a white glass. Rf = 0.27 (DCM/MeOH 5:1);
[a]D20 = +2.9 (c 0.26, MeOH); 1H NMR (400 MHz; CD3OD) d 7.40–
7.23 (m, 15H, Ph), 7.06 (d, J = 8.8 Hz, 2H, PMB), 6.80 (d, J = 8.8 Hz,
2H, PMB), 5.33–5.27 (m, 1H, H-1), 5.12 (d, J = 4.0 Hz, 1H, H-10),
4.81–4.75 (m, 3H, CH2Ph), 4.67 (d, 1H, J = 1.6 Hz, H-5), 4.65–4.61
(m, 3H, CH2Ph), 4.6 (br s, 1H, H-2), 4.51–4.48 (m, 2H, CH2Ph),
4.28–4.27 (m, 1H, H-3), 4.21–4.20 (m, 1H, H-4), 3.93–3.90 (m,
1H, H-30), 3.82–3.77 (m, 2H, H-60), 3.67–3.60 (m, 3H, H-20, H-40,
H-50), 3.74 (s, 3H, PMBOCH3), 3.42 (s, 3H, OCH3); 13C NMR
(100 MHz; CD3OD) d 175.7, 160.7, 139.4, 139.0, 131.6, 130.5,
129.4, 129.3, 129.2, 129.0, 128.8, 128.7, 128.6, 128.6, 114.6, 95.2,
82.7, 78.8, 76.5, 75.4, 74.4, 72.9, 72.9, 72.4, 71.2, 71.2, 71.1, 71.1,
70.9, 70.9, 69.3, 65.3, 55.6; FTMS (ESI) m/z calcd for C42H46N3O15
S1 [M2Na+H] 864.2655, found 864.2665.
5.1.9. Methyl 6-O-sulfonato-a-D-glucosaminopyranosyl-(1?4)-
2-O-sulfonato-a-L-idopyranoside uronate tri sodium salt 14
Disaccharide 12 (195 mg, 0.21 mmol) was dissolved in MeOH
(2 mL), THF (0.5 mL) and H2O (1 mL). Pd(OH)2/C (200 mg) was
added and the system purged with H2. Stirring was continued at
rt for 2 d. The suspension was then ﬁltered through Celite and sol-
vents removed in vacuo to reveal 14 (126 mg, 0.21 mmol, quant.)
as a clear glass. 1H NMR (400 MHz; D2O): d 5.04 (d, J = 3.6 Hz 1H,
H10), 4.98 (s, 1H, H1), 4.48 (d, J = 1.8 Hz, 1H, H-5), 4.32 (dd,
J = 11.1, 2.6 Hz, 1H, H-6A0), 4.23 (s, 1H, H-3), 4.18 (s, 1H, H-2),
4.14 (dd, J = 11.1, 2.1 Hz, 1H, H-6B0), 4.04 (s, 1H, H-4), 3.90 (dt,
J = 10.2, 2.2 Hz, 1H, H-50), 3.66 (t, J = 9.8 Hz, 1H, H-30), 3.47 (t,
J = 9.7 Hz, 1H, H40), 3.38 (s, 3H, OCH3), 2.89 (dd, J = 10.3, 3.2 Hz,
1H, H-20); FTMS (ESI) m/z calcd for C13H22NO17S2 [M3Na+2H]
528.0335, found 528.0335. Other analytical data matched those
previously reported.23
5.1.10. Methyl a–D-glucosaminopyranosyl-(1?4)-2-O-
sulfonato-a-L-idopyranoside uronate di sodium salt 15
Disaccharide 13 (107 mg, 0.12 mmol) was dissolved in MeOH/
H2O (3 mL/1 mL). To the ﬂask was attached a 3-way tap and the
system purged with N2. 10–20% Pd(OH)2/C (100 mg) was added
and the system purged with H2. Vigorous stirring having a balloon
with H2 attached (1 atm) was continued at rt for 36 h. The suspen-
sion was then ﬁltered through Celite and solvents removed in
vacuo to reveal 15 (56 mg, 0.11 mmol, 98%) as a clear glass.
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H2O); 1H NMR (400 MHz; D2O) d 5.15 (d, J = 3.6 Hz, 1H, H10), 4.97
(s, 1H, H-1), 4.46 (d, J = 1.7 Hz, 1H, H-5), 4.223–4.22 (m, 1H, H-3),
4.17 (ddd, J = 3.6, 2.4, 1.4 Hz, 1H, H-2), 4.03 (br s, 1H, H-4), 3.75–
3.71 (m, 3H, H-50, H-6A0, H-6B0), 3.67 (dd, J = 10.4, 9.3 Hz, 1H, H-
30), 3.41–3.36 (m, 4H, H40, OCH3), 2.92 (dd, J = 10.4, 3.6 Hz, 1H, H-
20); 13C NMR (100 MHz; D2O) d 175.3, 99.1, 94.2, 72.5, 71.9, 71.6,
71.1, 69.3, 66.2, 63.5, 59.9, 55.3, 54.6; ES MS 448.1 (M2Na+H).
Other analytical data matched those previously reported.23
5.1.11. Methyl 6-O,N-di-sulfonato-a-D-glucosaminopyranosyl-
(1?4)-2-O-sulfonato-a-L-idopyranoside uronate tetra sodium
salt 16
Disaccharide 14 (126 mg, 0.21 mmol) was dissolved in H2O
(3 mL) at rt NaHCO3 (176 mg, 2.1 mmol) and SO3pyr (167 mg,
1.05 mmol) were then added and the suspension stirred at room
temperature. Further additions of both these reagents were made
at 2 h and 4 h and stirring continued overnight. TLC analysis
(EtOAc/Pyr/H2O/AcOH; 6:5:3:1) showed no starting material
remained and a new species had formed on the baseline. Solvent
was removed in vacuo to reveal a crude white solid which was
puriﬁed by passage through a Sephadex G-20 resin using water
as eluent. The target material 16 (115 mg, 0.16 mmol, 79%) was
isolated as a white solid. 1H NMR (400 MHz; D2O) d 5.29 (d,
J = 3.5 Hz, 1H, H10), 5.03 (s, 1H, H-1), 4.43 (d, J = 2.3 Hz, 1H, H-5),
4.33 (dd, J = 11.1, 2.3 Hz, 1H, H-6A0), 4.20 (t, J = 1.5 Hz, 2H, H-2,
H-3), 4.16 (dd, J = 11.1, 2.1 Hz, 1H, H-6B0), 4.02–4.00 (m, 1H, H-
4), 3.93 (dt, J = 10.0, 2.1 Hz, 1H, H-50), 3.64 (dd, J = 10.3, 9.2 Hz,
1H, H-30), 3.54 (dd, J = 10.0, 9.3 Hz, 1H, H40), 3.38 (s, 3H, OCH3),
3.20 (dd, J = 10.3, 3.5 Hz, 1H, H-20); 13C NMR (100 MHz; D2O) d
174.9, 99.5, 97.4, 75.6, 74.6, 70.9, 69.9, 69.1, 67.49, 67.40, 66.4,
57.9, 55.4; FTMS (ESI) m/z calcd for C13H19NNa3O20S3 [MNa]
673.9349, found 673.9361. Other analytical data matched previ-
ously reported.23
5.1.12. Methyl N-sulfonato-a-D-glucosaminopyranosyl-(1?4)-
2-O-sulfonato-a-L-idopyranoside uronate tri sodium salt 17
Disaccharide 15 (40 mg, 0.08 mmol) was dissolved in H2O
(3 mL), NaHCO3 (41 mg, 0.49 mmol) and sulfurtrioxidepyridine
complex (39 mg, 0.25 mmol) were then added and the suspension
stirred at room temperature. Further additions of both these
reagents (same amounts) were made after 1, 3, 8 and 16 h and stir-
ring continued for another 8 h. Solvent was removed in vacuo to
reveal a crude white solid which was puriﬁed by passage through
Sephadex G-20 size exclusion resin using water as eluent. The tar-
get material 17 (44 mg, 0.07 mmol, 92%) was isolated as a white
solid. [a]D20 = +37.0 (c 0.70, H2O); 1H NMR (400 MHz; D2O) d 5.27
(d, J = 3.5 Hz, 1H, H10), 5.04 (s, 1H, H-1), 4.43 (d, J = 2.2 Hz, 1H, H-
5), 4.22–4.20 (m, 2H, H-2, H-3), 4.00 (br s, 1H, H-4), 3.81–3.74
(m, 3H, H-50, H-6A0, H-6B0), 3.63 (dd, J = 10.5, 9.2 Hz, 1H, H-30),
3.46–3.42 (m, 1H, H40), 3.38 (s, 3H, OCH3), 3.18 (dd, J = 10.5,
3.5 Hz, 1H, H-20); 13C NMR (100 MHz; D2O) d 175.2, 99.4, 97.3,
75.5, 74.4, 71.7, 70.9, 69.8, 67.3, 60.1, 58.0, 55.4; ES MS 550.0
(M2Na+H). Other analytical data matched those previously
reported.23
5.1.13. Methyl-a-D-glucosaminopyranosyl-(1?4)-a-L-
idopyranoside uronate mono sodium salt 18
Disaccharide 11 (75 mg, 0.20 mmol) was dissolved in EtOH/H2O
(5 mL/0.5 mL) and NaHCO3 (12 mg, 0.20 mmol) added. To the ﬂask
was attached a 3-way tap and purged with N2, 10–20% Pd(OH)2/C
(53 mg) was added and the system purged with H2. Vigorous stir-
ring having a balloon with H2 attached (1 atm.) was continued at
50 C for 32 h. The suspension was then ﬁltered through Celite
and solvents removed in vacuo to reveal 18 (42 mg, 0.11 mmol,95%) as a clear glass. [a]D20 = +52.2 (c 1.15, H2O); 1H NMR
(400 MHz; D2O) d 5.01 (d, J = 3.6 Hz, 1H, H10), 4.62 (d, J = 2.9 Hz,
1H, H-1), 4.33 (d, J = 2.7 Hz, 1H, H-5), 3.91 (t, J = 3.0 Hz, 1H, H-4),
3.86 (t, J = 4.3 Hz, 1H, H-3), 3.66–3.64 (m, 3H, H-50, H-6A0, H-6B0),
3.50–3.43 (m, 2H, H-2, H-30), 3.28–3.24 (m, 4H, H40, OCH3), 2.60
(dd, J = 10.2, 3.6 Hz, 1H, H-20); 13C NMR (100 MHz; D2O) d 175.2,
101.6, 96.4, 74.0, 73.2, 72.1, 69.6, 68.9, 68.60, 68.49, 60.2, 55.3,
55.0. Other analytical data matched those previously reported.23
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